Does Tufts Health Plan Cover Cialis?

What Does Tufts Health Plan Actually Say About Cialis Coverage?

Tufts Health Plan does not publish a single universal rule for Cialis. Coverage depends on which specific plan product you hold: Tufts Health Commercial (employer-sponsored), Tufts Health Public Plans (MassHealth managed care), Tufts Health Medicare Preferred (Medicare Advantage), or one of the ACA Marketplace plans sold through Massachusetts Health Connector. Each product has its own formulary, and formularies are updated at least annually.

The core pattern across most Tufts products in 2024 and 2025 is this: generic tadalafil is covered, brand-name Cialis is not preferred or is excluded entirely, and prior authorization applies to the daily 2.5 mg and 5 mg doses more often than to the as-needed 10 mg and 20 mg doses.

Generic Tadalafil vs. Brand-Name Cialis

The FDA approved the first generic tadalafil tablets in September 2018, and prices dropped sharply within 12 months. FDA generic drug approval records confirm multiple manufacturers now hold approval. As of 2025, a 30-tablet supply of generic tadalafil 5 mg costs roughly $15, $60 at most retail pharmacies without insurance.

Because the generic is therapeutically identical to brand Cialis, Tufts (like most large insurers) places brand Cialis at a high non-preferred tier or excludes it altogether. Members who receive a prescription written for "Cialis" will typically be dispensed the generic unless the prescriber writes "dispense as written," which usually triggers a non-preferred tier copay or a full out-of-pocket cost.

How Formulary Tiers Affect Your Copay

Tufts Health Plan uses a multi-tier formulary structure. For commercial plans, the approximate structure is:

• Tier 1 (preferred generics): $5, $15 copay per 30-day supply
• Tier 2 (non-preferred generics or preferred brands): $30, $60 copay
• Tier 3 (non-preferred brands): $60, $120 copay or 20 to 30% coinsurance
• Tier 4 / Specialty: percentage-based coinsurance, often 25 to 40%

Generic tadalafil sits at Tier 1 or Tier 2 on most Tufts commercial formularies. Brand Cialis, when listed at all, lands at Tier 3 or higher. Members on high-deductible health plans (HDHPs) pay the full negotiated cost until the deductible is met, regardless of tier.

Check your specific formulary on the Tufts Health Plan member portal or call Pharmacy Services at 1-888-880-8699 before assuming your plan mirrors the typical structure above.

Does Tufts Cover Cialis for Erectile Dysfunction?

Coverage for erectile dysfunction (ED) is more restricted than coverage for BPH (benign prostatic hyperplasia). This distinction matters because FDA-approved tadalafil labeling covers three separate indications: ED, BPH, and pulmonary arterial hypertension (PAH). The ICD-10 diagnosis code on the prescription claim signals which condition is being treated, and Tufts applies different coverage rules to each.

The ED Coverage Restriction

Massachusetts law does not mandate that commercial insurers cover ED medications. As a result, many employer-sponsored Tufts plans either exclude ED drugs outright or apply a quantity limit (for example, six tablets per 30-day supply for as-needed dosing). Some self-funded employer plans, which are governed by ERISA rather than state insurance law, go further and exclude all PDE5 inhibitors for ED entirely.

The FDA label for tadalafil distinguishes the 2.5 mg and 5 mg once-daily doses (approved for both BPH and ED) from the 10 mg and 20 mg as-needed doses (approved only for ED and PAH). Because the once-daily doses treat BPH, they are harder for plans to exclude without also restricting BPH coverage.

BPH Coverage Is Broader

Tufts Health Plan generally covers tadalafil 5 mg daily for BPH with fewer restrictions than for ED alone. BPH is a common, symptomatic, and well-documented condition affecting roughly 50% of men by age 60 and 90% by age 85, according to NIH statistics on BPH. A urologist or primary care physician prescribing tadalafil 5 mg daily with a primary ICD-10 code of N40.1 (BPH with lower urinary tract symptoms) will typically face less prior authorization friction than one prescribing the same drug with N52.9 (ED, unspecified).

Pulmonary Arterial Hypertension (PAH)

Tadalafil 20 mg (brand name Adcirca, now also available as generic) is FDA-approved for PAH. Coverage for PAH indications is generally strong across all Tufts plan types because PAH is a serious, potentially life-threatening condition. PAH-specific tadalafil claims are processed differently from ED claims and are not subject to the same exclusions.

Prior Authorization Requirements for Tadalafil on Tufts Plans

Prior authorization (PA) is the most common barrier members encounter. Tufts Health Plan requires PA for tadalafil on many of its plan products, and the specific criteria vary by indication and dose.

What PA Criteria Typically Look Like

For ED, Tufts PA criteria generally require:

1. A documented diagnosis of organic or mixed-etiology ED (not purely psychogenic)
2. A trial and failure, contraindication, or intolerance to sildenafil (generic Viagra) at an adequate dose for at least 4 weeks
3. A prescription from a licensed physician or advanced practice provider
4. No exclusion under the member's specific plan benefit language

For BPH, PA criteria are less stringent. Most plans require only a confirmed diagnosis with documented LUTS (lower urinary tract symptoms) and an adequate trial of an alpha-1 blocker such as tamsulosin 0.4 mg daily for 4 to 8 weeks, unless contraindicated.

How Long Does PA Approval Take?

Under Massachusetts regulations and federal requirements for Medicare plans, urgent PA requests must be decided within 72 hours, and standard requests within 3 business days for commercial plans. Medicare Advantage plans must meet CMS timelines: 72 hours for expedited requests and 7 calendar days for standard requests, per CMS guidance on Medicare Advantage prior authorization.

Step Therapy: The Sildenafil-First Requirement

Several Tufts commercial plans apply step therapy to tadalafil for ED. Step therapy means the plan requires you to try and document an inadequate response or intolerance to sildenafil (the generic for Viagra, available for roughly $10, $20 per month at Tier 1) before it will approve tadalafil. Massachusetts passed step therapy reform legislation, and under Massachusetts General Laws Chapter 176Q, members have the right to request a step therapy override if there is a clinical reason the first-step drug is inappropriate.

How to Get Tadalafil Covered: A Step-by-Step Process

The following framework is based on HealthRX's review of Tufts Health Plan formulary documents, Massachusetts insurance regulations, and clinical PA criteria patterns across commercial PDE5 inhibitor coverage policies.

Step 1: Confirm your formulary. Log into the Tufts Health Plan member portal at tuftshealthplan.com or call 1-888-880-8699 and request a formulary exception or PA form for tadalafil. Ask specifically whether your plan has an ED drug exclusion.

Step 2: Have your provider document the diagnosis precisely. The prescribing clinician should document the ICD-10 code accurately. If BPH is present alongside ED, both codes should appear in the chart. A urodynamics study, validated symptom score (IPSS for BPH, IIEF-5 for ED), and a note on prior alpha-blocker or sildenafil trials will support PA approval.

Step 3: Submit the PA request with supporting documentation. The prescriber submits the PA through Tufts' electronic PA system (CoverMyMeds is commonly used) or by fax. Include the diagnosis codes, relevant lab work (testosterone if low T is a contributing factor, HbA1c if diabetes is present), and documentation of any prior drug trials.

Step 4: If denied, file an internal appeal. Tufts must provide a written denial with the specific reason. Your provider can submit a peer-to-peer review request within 15 business days of the denial. Peer-to-peer calls with the plan's medical director resolve a meaningful percentage of ED-related PA denials when clinical documentation is thorough.

Step 5: File an external appeal if the internal appeal fails. Massachusetts members can request an independent external appeal through the Massachusetts Division of Insurance within 4 months of the internal denial. External appeals for step therapy overrides have a reasonable approval rate when the prescriber demonstrates clinical contraindication to the first-step agent.

What Tadalafil Costs Without Tufts Coverage

If your Tufts plan excludes ED coverage or your PA is denied, out-of-pocket options exist.

Generic Tadalafil Cash Prices

At major retail pharmacies in Massachusetts, 30 tablets of generic tadalafil 5 mg cost approximately $15, $45 using GoodRx or a pharmacy discount card. The 20 mg tablets (30-count) run roughly $30, $70. These prices are often lower than the cost-sharing on a Tier 3 branded drug claim.

GoodRx pricing data is updated regularly and reflects real-time pharmacy-negotiated rates. Prices vary by zip code and pharmacy chain.

90-Day Supply Savings

Ordering a 90-day supply through a mail-order pharmacy or a Tufts-preferred mail-order vendor (Express Scripts is commonly contracted by Tufts) can reduce per-unit cost by 20 to 30% even without insurance coverage. Cash-pay mail-order for tadalafil 5 mg 90-count runs roughly $30, $80 depending on the pharmacy.

Telehealth and Compounding Options

Telehealth platforms can prescribe tadalafil in cash-pay models at prices competitive with or below GoodRx rates. Some platforms offer sublingual or orally disintegrating formulations of tadalafil compounded by 503A pharmacies, though the FDA has noted concerns about some compounded PDE5 inhibitors that members should discuss with their physician.

Tadalafil Safety Profile: What Tufts' PA Criteria Are Protecting Against

PA criteria are not arbitrary gatekeeping. They exist partly because tadalafil carries real clinical contraindications that a coverage review can help flag.

Contraindications

The FDA tadalafil prescribing information lists absolute contraindications including:

• Concurrent use of any nitrate medication (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate). Co-administration can cause severe, potentially fatal hypotension.
• Concurrent use of soluble guanylate cyclase stimulators such as riociguat.
• Severe hepatic impairment (Child-Pugh Class C).

Relative contraindications include significant cardiovascular disease, uncontrolled hypertension (systolic <90 mmHg or >170 mmHg), and recent stroke or MI within 90 days. The Princeton Consensus Panel III recommendations, published in the Journal of Sexual Medicine, provide risk stratification guidance for PDE5 inhibitor use in men with cardiovascular disease.

Side Effects and Monitoring

Common adverse effects include headache (in roughly 11 to 15% of patients in clinical trials), flushing (in 4 to 12%), nasal congestion, dyspepsia, and myalgia, which is more common with tadalafil than with sildenafil due to tadalafil's inhibition of PDE11 in skeletal muscle. Back pain and myalgia occurred in 3 to 5% of patients in Phase III trials as summarized in published PubMed data.

Tadalafil for Women: Does Tufts Cover Off-Label Use?

Tadalafil is not FDA-approved for women. Off-label use in women (primarily studied in the context of female sexual dysfunction and pulmonary hypertension at lower doses) would not be covered by Tufts under standard formulary benefits. A prescriber could attempt a formulary exception citing published literature, but approval is unlikely without a PAH diagnosis.

The American College of Obstetricians and Gynecologists (ACOG) does not currently list tadalafil in its standard treatment protocols for female sexual dysfunction.

Medicare Advantage Members: Tufts Health Medicare Preferred and Tadalafil

Medicare Part D plans, including those offered through Tufts Health Medicare Preferred, are prohibited by federal law from covering drugs used "for the treatment of sexual or erectile dysfunction" unless the drug is also approved for another indication. This rule comes directly from 42 CFR 423.120(b)(12), which lists excluded drug categories for Part D.

What This Means Practically

For Medicare members, tadalafil 5 mg daily prescribed for BPH (not ED) may be covered because BPH is not an excluded indication. The claim must carry an appropriate BPH diagnosis code. The same drug prescribed for ED is excluded. PAH indications are also excluded from Part D but may be covered under Part B if administered in a clinical setting, though oral tadalafil for PAH is typically a Part D drug.

Tufts Health Medicare Preferred members who need tadalafil for ED should discuss cash-pay pricing with their physician or pharmacist. Generic tadalafil 5 mg is often available for <$1 per tablet through GoodRx at pharmacies in Massachusetts, making cash pay a practical option for many Medicare members.

Comparing Tufts to Other Massachusetts Insurers on Cialis Coverage

Tufts Health Plan's approach to tadalafil coverage is broadly consistent with other major Massachusetts commercial insurers including Blue Cross Blue Shield of Massachusetts, Harvard Pilgrim Health Care (now part of Point32Health, the same parent company as Tufts), and Fallon Health. All of them:

• Prefer generic tadalafil over brand Cialis
• Restrict ED-specific coverage more than BPH coverage
• Apply prior authorization for at least some tadalafil doses

The key difference between Tufts commercial and Tufts Medicare Preferred is the federal Part D exclusion for ED, which is binding regardless of what any state law says.

A 2019 analysis published in JAMA Internal Medicine found that coverage for PDE5 inhibitors varied widely across ACA Marketplace plans nationally, with fewer than 25% of benchmark plans covering sildenafil or tadalafil for ED without restriction. Tufts' restrictive approach for ED reflects a national pattern, not a policy specific to this insurer.

Talking to Your Doctor: What to Ask Before Submitting a PA

Getting the clinical documentation right before submitting a PA request saves time. At your appointment, ask your provider:

• "Can you document both my BPH and ED diagnoses if both are present?"
• "Have you documented my sildenafil trial in the chart, including the dose and duration?"
• "Will you submit a peer-to-peer review if the initial PA is denied?"
• "Is there a clinical reason I cannot use sildenafil that you can cite in the PA?"

The American Urological Association (AUA) guideline on erectile dysfunction recommends that clinicians discuss all PDE5 inhibitors as first-line agents for organic ED, with selection based on patient preference and dosing schedule rather than one drug being superior to another. This guideline language is useful to cite in a PA appeal because it supports tadalafil as a clinically appropriate first-line agent rather than a second-line option requiring step therapy through sildenafil.